Author:
Gupta AK,Leonardi C,Stoltz RR,Pierce PF,Conetta B,
Subject
Infectious Diseases,Dermatology
Reference12 articles.
1. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis
2. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole
3. In Vitro Activity of the New Triazole BMS-207147 against
Aspergillus
Species in Comparison with Itraconazole and Amphotericin B
4. 4EF Brega, G Gonzalez, and W Fothergill et al.Anin vitroevaluation of new triazole antifungal agents against clinical isolates of dermatophytes in comparison with terbinafine, itraconazole and fluconazole . Abstract 841. Page 23. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.Toronto, Canada, 2000 .
5. 5DM Grasela, SJ Olsen, and V Mummanen et al.Ravuconazole: multiple ascending oral dose study in healthy subjects . Abstract 839, Page 22. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.Toronto, Canada2000 .
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献